Somnomed Ltd has released a press release.
Somnomed: Replacement Prospectus
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Somnomed
- Reinstatement to Quotation
- Completion of institutional component of Entitlement Offer
- Revised guidance and capital raising
- Prospectus Entitlement Offer
- Update on voluntary suspension & FY24 earnings guidance
Later from Somnomed
- Completion of retail component of Entitlement Offer
- Preliminary Final Report
- FY24 Preliminary Report and FY25 Guidance
- Investor Presentation
- Rest Assure - US Food and Drug Authority (FDA) Update
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed